FASN is a critical enzyme in the adipose de novo pathway in NASH patients, where it is primarily responsible for synthesizing extra fat and triggering fibrosis and inflammation (118). This evidence concerns the gene FASN and metabolic dysfunction-associated steatohepatitis.